为什么女性在接受肺癌查时似乎有更好的结果
Gerard A Silvestri1,2, Ralph C Ward3, Raewyn J Scott4
1Medical University of South Carolina, Pulmonary and Critical Care, charleston, United States.
Annals of the American Thoracic Society
|February 18, 2025
概括
与男性相比,女性在查计算机断层扫描 (CT) 时经历了更大的肺癌死亡率降低. 这可能是由于男性的并发病率较高,导致男性的整体和肺癌死亡率增加.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
背景情况:
- 随机对照试验 (RCT) 显示,使用计算机断层扫描 (CT) 的肺癌查 (LCS) 与胸部放射 (CXR) 相比,降低了死亡率.
- 女性似乎比男性更受益于LCS,但原因尚不清楚.
研究的目的:
- 调查LCS结果中观察到的基于性别的差异背后的原因.
- 从CT查分析性别对肺癌死亡率降低的影响.
主要方法:
- 国家肺部查试验 (NLST) 数据的二次分析.
- 使用了描述性统计数据和竞争风险比例危险模型.
- 检查了性别查结果的差异,包括性别和查臂之间的相互作用.
主要成果:
- 肺癌 (LC) 死亡率在女性 (1.7%) 低于男性 (2.1%) 整体.
- CT查显示,女性的LC死亡率显著降低 (sHR=0.74),但男性的LC死亡率没有降低 (sHR=0.91).
- 伴随性疾病,如COPD和心脏病,在男性中更为普遍,与LC死亡的增加有关.
结论:
- 妇女在CT查时,LC死亡率下降更大,尽管在统计学上并不显著.
- 伴随性疾病在男性中更高的患病率可能解释了他们增加的全因和LC死亡率.
- 这些发现表明,性别特异性因素会影响LCS的有效性.
更多相关视频
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.6K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
相关概念视频
Statistical Methods for Analyzing Epidemiological Data
1.3K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.3K
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
